Mutating a single amino acid (serine to isoleucine at position 267) in the glycine receptor alpha1 subunit abolished the ability of CBD, ajulemic acid, and HU210 to modulate glycine receptor function.
Read this if you study pain pharmacology or cannabinoid mechanisms beyond CB1/CB2 receptors.
One amino acid change abolished all cannabinoid-glycine receptor interactions
What the researchers found
Loss of inhibitory glycine signaling in the spinal cord plays a key role in chronic pain. Recent research suggested that cannabinoids might relieve pain partly by modulating glycine receptors, independent of cannabinoid receptors.
Researchers tested three non-psychotropic cannabinoids (ajulemic acid, CBD, and HU210) on glycine receptors with a specific mutation: serine to isoleucine at position 267 in the transmembrane domain.
This single amino acid change completely abolished the ability of all three cannabinoids to co-activate or directly activate glycine receptors.
This demonstrated that position 267 in the TM2 domain is crucial for cannabinoid-glycine receptor interactions, providing insight into the molecular basis of cannabinoid pain relief through non-CB1/CB2 mechanisms.
Why it matters
Understanding how cannabinoids relieve pain through non-cannabinoid receptor mechanisms (like glycine receptors) could lead to pain medications that work through the cannabinoid-glycine interaction without producing psychoactive effects.
The numbers in context
One amino acid mutation (S267I) abolished all cannabinoid-glycine receptor interactions. Three cannabinoids tested: ajulemic acid, CBD, HU210. All effects eliminated by the mutation.
How the study worked
In vitro electrophysiology study. Mutated alpha1(S267I) glycine receptors were expressed in HEK293 cells and studied using whole-cell patch clamp technique. Three cannabinoids (ajulemic acid, cannabidiol, HU210) were tested for their ability to modulate glycine receptor currents.
What this study cannot tell us
In vitro study using recombinant receptors in cell lines, not native neurons. The mutation may affect receptor function in ways beyond cannabinoid interactions. Whether this mechanism contributes significantly to pain relief in living organisms was not tested.
How to read the evidence
In vitro electrophysiology study with recombinant receptors. Provides precise molecular data but limited translational relevance.
When this study was published
Published in 2010. The cannabinoid-glycine receptor interaction has continued to be studied as a potential target for non-psychoactive pain treatments.
The bigger picture
Pain relief through glycine receptor modulation represents a fundamentally different mechanism from traditional cannabinoid receptor activation. Drugs designed to exploit this specific interaction could potentially provide pain relief without the psychoactive effects or abuse potential of THC.
Questions still open
- How important is glycine receptor modulation for the overall analgesic effect of cannabinoids? Could drugs be designed to specifically target the cannabinoid-glycine receptor interaction? Do natural variations in glycine receptor genes affect pain responses to cannabinoids?
Common questions
What are glycine receptors?
Why does this matter for CBD pain relief?
Read the original research
Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids.
Naunyn-Schmiedeberg's archives of pharmacology, 381(5), 477-82
Citation
Foadi, Nilufar; Leuwer, Martin; Demir, Reyhan; Dengler, Reinhard; Buchholz, Vanessa; de la Roche, Jeanne; Karst, Matthias; Haeseler, Gertrud; Ahrens, Jörg. (2010). Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids.. Naunyn-Schmiedeberg's archives of pharmacology, 381(5), 477-82. https://doi.org/10.1007/s00210-010-0506-9
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk